Virpax Pharmaceuticals (VRPX) Pharmaceuticals Updates on Litigation

Virpax® Pharmaceuticals, Inc. (NASDAQ: VRPX) today announced that it has received a ruling on the lawsuit filed by Scilex Pharmaceuticals (NASDAQ: SCLX) and Sorrento Therapeutics, the now bankrupt majority owner of Scilex Pharmaceuticals.

The Court found in favor of the plaintiffs (on all but three counts deemed to have been waived). However, no damages judgment was specified in the ruling which called for additional proceedings to determine the remedy.

You May Also Be Interested In

• Huang Calls AI 'the Great Equalizer' During G20 Event
• Quantum Cyber names Tzvi Lev as head of Middle East sales
• Founder Group bids for Malaysia's RM13–15B solar programme